Pharmacists Publications
2025
- Weibe, A., Pecson, R., Coupland, M., Halpape, K. (2025). Role of Pharmacists in Addiction Medicine in Canada’s Publicly Funded Health Care Systems: A Qualitative Study. Can J Hospital Pharm. 78(2). doi:https://doi.org/10.4212/cjhp.3680
2023
- Jorgenson D, Halpape K, Siton M. (2023). Health professional perceptions of a pharmacist-led interprofessional chronic pain clinic. Can Pharm J (Ott). 157(1):25-29.
2022
- Gondora N, Versteeg SG, Carter C, Bishop LD, Sproule B, Turcotte D, Halpape K, Beazely MA, Dattani S, Kwong M, Nissen L, Chang F. (2022). The role of pharmacists in opioid stewardship: A scoping review. Res Social Adm Pharm. 18(5):2714-2747.
- MacAusland-Berg J, Wiebe A, Marwah R, Halpape K. (2022). Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report. Can J Pain. 6(1):135-141.
2021
- Halpape K, Jorgenson D, Ahmed A, Kizlyk K, Landry E, Marwah R, Raiche T, Wiebe A. (2021). Pharmacist-led strategy to address the opioid crisis: The Medication Assessment Centre Interprofessional Opioid Pain Service (MAC iOPS). Can Pharm J (Ott). 155(1):21-25.
- Fatani S, Bakke D, D’Eon M, El-Aneed A. (2021).Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management. Substance Abuse Treatment, Prevention, and Policy. 16(38). https://doi.org/10.1186/s13011-021-00374-x
2019
- Fatani S, Dobson R, El-Aneed A. (2019). Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder. Can Pharm J (Ott). 152(2):117-129. doi: 10.1177/1715163518816726. PMID: 30886664; PMCID: PMC6410432.
2013
- Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. (2013). Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy. 8:35.
